The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Conversion surgery for tislelizumab combined chemotherapy for T4a/N3 esophageal squamous cell carcinoma (ESCC): A prospective, single-arm, phase II study.
 
Chen Zhang
No Relationships to Disclose
 
Xiaobin Shang
No Relationships to Disclose
 
Jie Yue
No Relationships to Disclose
 
Chuangui Chen
No Relationships to Disclose
 
Xiaofeng Duan
No Relationships to Disclose
 
Zhao Ma
No Relationships to Disclose
 
Zuoyu Chen
No Relationships to Disclose
 
Shangren Wang
No Relationships to Disclose
 
Gang Zhao
No Relationships to Disclose
 
Liang Liu
No Relationships to Disclose
 
Weihong Zhang
No Relationships to Disclose
 
Runmei Li
No Relationships to Disclose
 
Yanjuan Xiong
No Relationships to Disclose
 
Fan Yang
No Relationships to Disclose
 
Jianyu Xiao
No Relationships to Disclose
 
Fuliang Cao
No Relationships to Disclose
 
Feng Guo
No Relationships to Disclose
 
Dejun Zhou
No Relationships to Disclose
 
Xiubao Ren
No Relationships to Disclose
 
Hongjing Jiang
No Relationships to Disclose